Back

Heart failure therapies: focus on MRAs/K binders and SGLT2i

28 November 2025 (11:30 - 11:42)
Organised by: Logo
Seminar Presentation Part of: SESSION IV - TTR-related Cardiac amyloidosis: therapeutic challenges (joint with HFA Cardiac Amyloidosis Committee) Pericardial Disease, Other Open Access M&PD Annual meeting 2025 WG on Myocardial and Pericardial Diseases

About the speaker

Photo
Doctor Aldostefano Porcari

Cattinara Hospital - Cardiology Centre, Trieste (Italy)

4 More presentations in this session

Presentation thumbnail
Real-world data
Doctor F. Cappelli (Florence, IT)
Slides
Presentation thumbnail
Specific therapy: tafamidis, acoramidis, what else?
Mr P. Garcia Pavia (Madrid, ES)
Slides
Presentation thumbnail
Stabilizers, Gene silencing/editing, Depletors: how can we select the best candidates?
Professor M. Emdin (Pisa, IT)
Presentation thumbnail
Lecture - Risk stratification in DCM/NDLVC
Professor P. Elliott (London, GB)
Slides

Access the full session

Session thumbnail
SESSION IV - TTR-related Cardiac amyloidosis: therapeutic challenges (joint with HFA Cardiac Amyloidosis Committee)

The Event

Event poster

M&PD Annual meeting 2025

28 November 2025 11:30 CET
You may be interested in
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025
thumbnail
Congress Presentation
Contemporary use of SGLT2i therapy among patients hospitalized for heart failure with reduced ejection fraction in the United States
22 May 2023
thumbnail
Congress Presentation
Optimising heart failure therapy: potassium binders and the initiation and titration of mineralocorticoid receptor antagonists
19 May 2025
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources